Late onset spondyloarthropathy mimicking polymyalgia rheumatica.
We report a 55-year-old woman with late onset spondyloarthropathy who had widespread body pain and pitting oedema of both ankles. She had been followed up for polymyalgia rheumatica for nearly 10 years. On laboratory examination, ESR: 62 mm/h and CRP: 16.1 mg/dl. HLA was positive. There was tenderness on both of her ankles. We diagnosed late onset spondyloarthropathy according to clinic and radiographic findings. The patient was treated with sulphasalazine 200 mg/day and indomethacin 100 mg/day. As a conclusion, LoSPA may mimic a variety of rheumatic conditions such as PMR and reflex sympathetic dystrophy syndrome. Careful examination should be warranted in such conditions.
Aydeniz
Ali
A
Gaziantep University, Gaziantep, Turkey. aydeniz@gantep.edu.tr
Altındağ
Ozlem
O
Oğüt
Evrim
E
Gürsoy
Savaş
S
D017668:Age of Onset; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000378:metabolism; D003951:Diagnostic Errors; D004359:Drug Therapy, Combination; D004487:Edema / Q000209:etiology; D005260:Female; D015796:HLA-B27 Antigen / Q000097:blood; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D011111:Polymyalgia Rheumatica / Q000175:diagnosis*; D011237:Predictive Value of Tests; D025242:Spondylarthropathies / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D012460:Sulfasalazine / Q000627:therapeutic use; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D015415:Biomarkers; C090660:HLA-B protein, human; D015796:HLA-B27 Antigen; D012460:Sulfasalazine; D002097:C-Reactive Protein; D007213:Indomethacin